Fisetin vs Quercetin: Which Senolytic Has Better Evidence?

Expert Summary

Fisetin and quercetin share a flavonoid backbone and both function as natural senolytics through BCL-2 family inhibition. Fisetin has the stronger preclinical senolytic evidence (Scripps Research 2018), while quercetin has more robust human clinical trial data via the D+Q (dasatinib + quercetin) combination protocol from the Mayo Clinic.

Key Facts

• Senolytic potency: In head-to-head cell culture studies, fisetin shows greater senolytic potency than quercetin at equivalent concentrations. The IC50 for senescent cell killing is lower for fisetin across multiple cell types.
• Clinical evidence: Quercetin leads on human clinical data as part of the D+Q protocol (Xu et al. 2019, Nature Medicine). Fisetin has ongoing human trials but peer-reviewed efficacy data is still emerging.
• Bioavailability: Standard quercetin bioavailability (~1–5%) is lower than fisetin (~5–15%). Quercetin phytosome corrects this dramatically; fisetin phytosome and liposomal forms similarly improve absorption.
• Food sources: Quercetin is more abundant in the food supply (capers, onions, apples, kale) than fisetin (primarily strawberries). Neither food source provides therapeutic senolytic doses.
• Cost: At equivalent dosing, fisetin and quercetin have similar cost profiles. High-absorption phytosome forms of both are more expensive but may offer better value per absorbed milligram.
• Combination rationale: Fisetin and quercetin inhibit overlapping but not identical BCL-2 family members. Combining them broadens the cellular targets and may achieve superior clearance of diverse senescent cell populations.

Recommended Products

Frequently Asked Questions

Should I take fisetin or quercetin first?

Start with fisetin if you want the single agent with the strongest preclinical senolytic evidence. Start with quercetin if you prefer alignment with the most human trial data (D+Q protocol). Many practitioners use both in rotation.

Can fisetin and quercetin be taken on the same day?

Yes. Both are flavonoids with complementary mechanisms. Taking them together on burst dosing days is a common and safe approach. No antagonistic interactions have been documented.

Which is better for brain health specifically?

Fisetin has a better documented blood-brain barrier penetration profile and more neuroprotection studies. For cognitive aging specifically, fisetin may be the preferred single agent.

Scientific References

• Yousefzadeh MJ et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018. PMID: 30279143
• Xu M et al. Senolytics improve physical function and increase lifespan. Nature Medicine. 2018. PMID: 29988130